Refine Search
(100)
(399)
(917)
(1779)

NEW Global Risk Report Quarterly Update: Q4 2018

  • $1,100
  • March 2019
Add to Basket Quick View Add to Saved List

Global Risk Report is based on GlobalData Country Risk Index (GCRI) which is a unique country risk-rating model that determines the existing and future level of country risk by assessing various qualitative and quantitative factors. The index i...

NEW Gastrointestinal Disorders: Innovative Pipeline Offers Potential for First Approved Therapies in NASH and Celiac Disease

  • $6,995
  • March 2019
Add to Basket Quick View Add to Saved List

The burden of disease associated with gastrointestinal disorders is considerable with many of these disorders being highly prevalent. Additionally, many GI disorders are chronic in nature and are associated with significant impairments in quali...

NEW Chronic Kidney Disease–Mineral Bone Disorders (CKD-MBD): Competitive Landscape to 2027

  • $3,495
  • March 2019
Add to Basket Quick View Add to Saved List

Chronic Kidney Disease–Mineral Bone Disorders (CKD-MBD) is one of the many complications associated with overall CKD. The systemic disorder is identified from high parathyroid hormone and disrupted K+/Ca2+ levels caused by a decreasing glomerul...

NEW Idiopathic Pulmonary Fibrosis: Competitive Landscape to 2026

  • $3,495
  • March 2019
Add to Basket Quick View Add to Saved List

Idiopathic pulmonary fibrosis (IPF) is a progressive disease that results in the scarring of lung tissue and changes the lung’s ability to function normally. The most common signs and symptoms of idiopathic pulmonary fibrosis are dyspnea and a ...

NEW Multiple Myeloma: Global Drug Forecast and Market Analysis to 2027

  • $10,995
  • March 2019
Add to Basket Quick View Add to Saved List

Multiple myeloma (MM) is a cancer of abnormal plasma cells, a type of white blood cell that is normally responsible for producing antibodies in the bone marrow. Significant improvements in progression-free survival and overall survival arrived ...

NEW Multiple Myeloma: Epidemiology Forecast to 2027

  • $3,995
  • March 2019
Add to Basket Quick View Add to Saved List

Multiple myeloma (MM) (International Statistical Classification of Diseases and Related Health Problems, 10th Revision [ICD-10] code = C90.0) is a hematologic cancer that forms in a type of white blood cell called a plasma cell.

In 2017, ...

Chimeric Antigen Receptor Cell Therapy

  • $7,995
  • February 2019
Add to Basket Quick View Add to Saved List

Chimeric antigen receptor (CAR) cell therapy is an immuno-oncology (IO) approach that has gained increasing momentum in the past few years, with the approval of two new therapies in 2017 (US) and 2018 (EU). Novartis’ Kymriah (tisagenlecleucel) ...

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape – India

  • $1,995
  • February 2019
Add to Basket Quick View Add to Saved List

GlobalData, the industry analysis specialist, has released its latest report, “CountryFocus: Healthcare, Regulatory and Reimbursement Landscape – India”. The report is an essential source of information and analysis on the healthcare, regulator...

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape – China

  • $1,995
  • January 2019
Add to Basket Quick View Add to Saved List

GlobalData, the industry analysis specialist, has released its latest report, “CountryFocus: Healthcare, Regulatory and Reimbursement Landscape – China”. The report is an essential source of information and analysis on the healthcare, regulator...

Rheumatoid Arthritis: Global Drug Forecast and Market Analysis to 2027

  • $10,995
  • January 2019
Add to Basket Quick View Add to Saved List

Rheumatoid arthritis (RA) is an autoimmune disease that, due to a complex interplay of environmental, immunological, and genetic factors, causes chronic inflammation and progressive deformity of the joints over time.

In 2017, the diagnose...

Rheumatoid Arthritis: Epidemiology Forecast to 2027

  • $3,995
  • January 2019
Add to Basket Quick View Add to Saved List

Rheumatoid arthritis (RA) is an autoimmune disease characterized by inflammation of the joints, bone and cartilage erosion, and joint deformity. Additionally, the condition manifests itself in multiple joints in the body. In RA, the body’s immu...

The State of the Microbiome

  • $1,495
  • January 2019
Add to Basket Quick View Add to Saved List

This report provides an assessment of how the pharmaceutical industry perceives the state of the microbiome, including the challenges associated with developing, launching, and manufacturing microbiome therapeutics as well as where opportunity ...

Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals – Q3 2018

  • $1,500
  • January 2019
Add to Basket Quick View Add to Saved List

GlobalData's “Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals – Q3 2018” report is an essential source of data and trend analysis on partnerships, licensing, mergers and acquisitions (M&As) and finan...

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape – UK

  • $1,995
  • December 2018
Add to Basket Quick View Add to Saved List

GlobalData, the industry analysis specialist, has released its latest report, “CountryFocus: Healthcare, Regulatory and Reimbursement Landscape – UK”. The report is an essential source of information and analysis on the healthcare, regulatory a...

Psoriatic Arthritis: Competitive Landscape to 2026

  • $3,495
  • December 2018
Add to Basket Quick View Add to Saved List

Psoriatic arthritis is a chronic immune-mediated arthritis that typically affects the large joints, including those of the lower extremities, the distal joints of the fingers and toes, the back, and sacroiliac joints of the pelvis. Up to 30% of...

Join our mailing list
Find out first about the latest reports and offers.
Report Catalogue

Strategic Insight Reports

Market Analysis Reports

Databooks